SOLVENTUM CORP (SOLV) Fundamental Analysis & Valuation

NYSE:SOLVUS83444M1018

Current stock price

68.52 USD
-0.44 (-0.64%)
At close:
68.52 USD
0 (0%)
After Hours:

This SOLV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SOLV Profitability Analysis

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • SOLV had a positive operating cash flow in the past year.
  • Each year in the past 5 years SOLV has been profitable.
  • In the past 5 years SOLV always reported a positive cash flow from operatings.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 10.89%, SOLV belongs to the top of the industry, outperforming 91.98% of the companies in the same industry.
  • With an excellent Return On Equity value of 30.82%, SOLV belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 5.40%, SOLV is doing good in the industry, outperforming 75.94% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLV is in line with the industry average of 9.12%.
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROIC 5.4%
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SOLV has a Profit Margin of 18.69%. This is amongst the best in the industry. SOLV outperforms 94.12% of its industry peers.
  • In the last couple of years the Profit Margin of SOLV has grown nicely.
  • SOLV has a better Operating Margin (8.53%) than 77.01% of its industry peers.
  • SOLV's Operating Margin has declined in the last couple of years.
  • SOLV has a Gross Margin of 53.57%. This is comparable to the rest of the industry: SOLV outperforms 50.27% of its industry peers.
  • SOLV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

2

2. SOLV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SOLV is creating some value.
  • The number of shares outstanding for SOLV has been increased compared to 1 year ago.
  • SOLV has a better debt/assets ratio than last year.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.75. This is a bad value and indicates that SOLV is not financially healthy and even has some risk of bankruptcy.
  • SOLV has a Altman-Z score (1.75) which is comparable to the rest of the industry.
  • SOLV has a Debt/Equity ratio of 1.00. This is a neutral value indicating SOLV is somewhat dependend on debt financing.
  • SOLV has a worse Debt to Equity ratio (1.00) than 77.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.75
ROIC/WACC0.69
WACC7.82%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • SOLV has a Current Ratio of 1.23. This is a normal value and indicates that SOLV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SOLV (1.23) is worse than 87.17% of its industry peers.
  • A Quick Ratio of 0.89 indicates that SOLV may have some problems paying its short term obligations.
  • SOLV has a worse Quick ratio (0.89) than 85.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.89
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1B 2B 3B

4

3. SOLV Growth Analysis

3.1 Past

  • The earnings per share for SOLV have decreased by -8.82% in the last year.
  • Measured over the past 5 years, SOLV shows a small growth in Earnings Per Share. The EPS has been growing by 4.46% on average per year.
  • Looking at the last year, SOLV shows a small growth in Revenue. The Revenue has grown by 0.86% in the last year.
  • The Revenue has been growing slightly by 0.79% on average over the past years.
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%

3.2 Future

  • Based on estimates for the next years, SOLV will show a small growth in Earnings Per Share. The EPS will grow by 6.90% on average per year.
  • The Revenue is expected to grow by 1.37% on average over the next years.
EPS Next Y7.95%
EPS Next 2Y8.36%
EPS Next 3Y8.89%
EPS Next 5Y6.9%
Revenue Next Year-1.18%
Revenue Next 2Y1.03%
Revenue Next 3Y2.01%
Revenue Next 5Y1.37%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2 4 6

6

4. SOLV Valuation Analysis

4.1 Price/Earnings Ratio

  • SOLV is valuated reasonably with a Price/Earnings ratio of 11.23.
  • SOLV's Price/Earnings ratio is rather cheap when compared to the industry. SOLV is cheaper than 90.91% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SOLV to the average of the S&P500 Index (27.42), we can say SOLV is valued rather cheaply.
  • The Price/Forward Earnings ratio is 10.41, which indicates a very decent valuation of SOLV.
  • Based on the Price/Forward Earnings ratio, SOLV is valued cheaply inside the industry as 94.65% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of SOLV to the average of the S&P500 Index (22.24), we can say SOLV is valued rather cheaply.
Industry RankSector Rank
PE 11.23
Fwd PE 10.41
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SOLV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SOLV is cheaper than 82.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.38
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)1.41
PEG (5Y)N/A
EPS Next 2Y8.36%
EPS Next 3Y8.89%

0

5. SOLV Dividend Analysis

5.1 Amount

  • SOLV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SOLV Fundamentals: All Metrics, Ratios and Statistics

SOLVENTUM CORP

NYSE:SOLV (4/24/2026, 8:09:03 PM)

After market: 68.52 0 (0%)

68.52

-0.44 (-0.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners73.51%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner Change0.41%
Market Cap11.88B
Revenue(TTM)8.32B
Net Income(TTM)1.56B
Analysts73.33
Price Target87.95 (28.36%)
Short Float %3.65%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.79%
Min EPS beat(2)2.66%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)8
Avg EPS beat(8)8.33%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.15%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-0.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.52%
PT rev (3m)-2.74%
EPS NQ rev (1m)0.15%
EPS NQ rev (3m)-7.9%
EPS NY rev (1m)0.25%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)2.16%
Valuation
Industry RankSector Rank
PE 11.23
Fwd PE 10.41
P/S 1.43
P/FCF N/A
P/OCF 32.2
P/B 2.35
P/tB N/A
EV/EBITDA 13.38
EPS(TTM)6.1
EY8.9%
EPS(NY)6.58
Fwd EY9.61%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.13
OCFY3.11%
SpS48.01
BVpS29.12
TBVpS-18.72
PEG (NY)1.41
PEG (5Y)N/A
Graham Number63.2152 (-7.74%)
Profitability
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROCE 6.36%
ROIC 5.4%
ROICexc 5.87%
ROICexgc 30.39%
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
FCFM N/A
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
ROICexc(3y)8.79%
ROICexc(5y)10.16%
ROICexgc(3y)43.79%
ROICexgc(5y)51.79%
ROCE(3y)9.88%
ROCE(5y)11.65%
ROICexgc growth 3Y-18.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.41%
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 77.51%
Cap/Sales 4.55%
Interest Coverage 1.61
Cash Conversion 30.78%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.89
Altman-Z 1.75
F-Score6
WACC7.82%
ROIC/WACC0.69
Cap/Depr(3y)65.89%
Cap/Depr(5y)57.5%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y7.95%
EPS Next 2Y8.36%
EPS Next 3Y8.89%
EPS Next 5Y6.9%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-1.18%
Revenue Next 2Y1.03%
Revenue Next 3Y2.01%
Revenue Next 5Y1.37%
EBIT growth 1Y-31.93%
EBIT growth 3Y-24.87%
EBIT growth 5YN/A
EBIT Next Year19.67%
EBIT Next 3Y10.8%
EBIT Next 5Y5.63%
FCF growth 1Y-101.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.86%
OCF growth 3Y-39.65%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


What is the profitability of SOLV stock?

SOLVENTUM CORP (SOLV) has a profitability rating of 7 / 10.


What is the financial health of SOLVENTUM CORP (SOLV) stock?

The financial health rating of SOLVENTUM CORP (SOLV) is 2 / 10.


What is the expected EPS growth for SOLVENTUM CORP (SOLV) stock?

The Earnings per Share (EPS) of SOLVENTUM CORP (SOLV) is expected to grow by 7.95% in the next year.